Weighing Obesity Risk: FDA, EMEA Use Different Scales For Abbott's Meridia

After additional cardiovascular events are seen, European regulators move to pull sibutramine, while FDA asks for a contraindication.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet